active
ACTIVE SINCE: 2018

Expanding One-Stop-Shop Diabetes Care Model across Mexico and U.S.

Validate effectiveness of a ‘one-stop-shop’ diabetes model and test key drivers for keeping people in the cascade of care and expand CdA’s model in the U.S. to provide 'one-stop-shop' diabetes care for immigrant populations in Texas and other border states.
SGDS CONTRIBUTING TO:
MEMBER COMPANIES:
Hospitals Health Facilities 1
Academia or research institute 1

Lilly is working with Clinicas del Azúcar (Sugar Clinics) and MIT on a six-year effort to validate and expand a comprehensive diabetes care model and related efforts that engage underserved patients in improving their health over the long term. The efficacy of the model of care has been validated, and Clinicas del Azucar has leveraged this evidence to significantly expand the number of clinics and people served across Mexico with 37 clinics and close to 300,000 beneficiaries to date. In the coming year, Lilly is supporting Clinicas del Azucar’s model for further expansion into the United States to provide low-cost improved diabetes management and care with the potential to reach 1 million vulnerable Latinx patients by 2030 and in Texas and other border states.

Results and milestones

Partnership was launched in late 2018.

Geographic Reach
  • Americas
See Where
Disease Area
  • Non-communicable Diseases
See Disease Areas
SGDs the partnership contributes to
SDG 3: Good Health and Wellbeing
  1. 3.2: Reduce Under-5 Mortality 
  2. 3.4: NCDs (including mental health)
  3. 3.8: Achieve universal health coverage
SDG 5: Gender Equality
SDG 17: Partnerships for the Goals 
Partner organizations
Hospitals Health Facilities

Clinicas del Azucar

Academia or research institute

Massachusetts Institute of Technology (MIT)